Mentice AB Cash Flow Conversion Efficiency
Mentice AB cash flow conversion efficiency. Based on the latest financial reports, Mentice AB (MNTC) has a cash flow conversion efficiency ratio of 0.067x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr8.33 Million ≈ $896.66K USD) by net assets (Skr123.58 Million ≈ $13.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Mentice AB (2017–2025)
Cash flow conversion efficiency of Mentice AB from 2017 to 2025. This chart illustrates how Mentice AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Mentice AB for real-time trading data and today's change.
Mentice AB Cash Flow Conversion Ratio Explained
Mentice AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Mentice AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mentice AB ranked by their cash flow conversion efficiency. Also see market value of Mentice AB for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sarveshwar Foods Limited
NSE:SARVESHWAR
|
-0.002x |
|
Chemfab Alkalis Limited
NSE:CHEMFAB
|
0.030x |
|
Aeye Inc
NASDAQ:LIDR
|
-0.107x |
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
0.063x |
|
Werewolf Therapeutics Inc
NASDAQ:HOWL
|
0.407x |
|
Ramaco Resources Inc.
NASDAQ:METCB
|
-0.079x |
|
seha corporation
KO:027970
|
0.017x |
|
Kodiak Copper Corp
V:KDK
|
-0.019x |
Annual Cash Flow Conversion Efficiency for Mentice AB (2017–2025)
The table below shows the annual cash flow conversion efficiency of Mentice AB from 2017 to 2025. Review Mentice AB free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr138.38 Million ≈ $14.89 Million |
Skr-20.30 Million ≈ $-2.18 Million |
-0.147x | -217.61% |
| 2024-12-31 | Skr143.66 Million ≈ $15.46 Million |
Skr17.92 Million ≈ $1.93 Million |
0.125x | -45.70% |
| 2023-12-31 | Skr158.97 Million ≈ $17.11 Million |
Skr36.52 Million ≈ $3.93 Million |
0.230x | +150.59% |
| 2022-12-31 | Skr162.63 Million ≈ $17.50 Million |
Skr14.91 Million ≈ $1.60 Million |
0.092x | +344.60% |
| 2021-12-31 | Skr136.89 Million ≈ $14.73 Million |
Skr-5.13 Million ≈ $-552.07K |
-0.037x | -120.04% |
| 2020-12-31 | Skr163.25 Million ≈ $17.57 Million |
Skr30.53 Million ≈ $3.29 Million |
0.187x | +162.59% |
| 2019-12-31 | Skr124.77 Million ≈ $13.43 Million |
Skr-37.28 Million ≈ $-4.01 Million |
-0.299x | -224.60% |
| 2018-12-31 | Skr66.74 Million ≈ $7.18 Million |
Skr16.00 Million ≈ $1.72 Million |
0.240x | -25.85% |
| 2017-12-31 | Skr48.64 Million ≈ $5.23 Million |
Skr15.73 Million ≈ $1.69 Million |
0.323x | -- |
About Mentice AB
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedura… Read more